Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Stage I Prostate Adenocarcinoma AJCC v7 × Congresses as Topic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stage I Prostate Adenocarcinoma AJCC v7 1

Interventions

nilutamide 1 luprolide acetate gel depot 1 bicalutamide 1 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1 Salicylic Acid 1 Radiation 1 Leuprolide 1 Goserelin 1 Flutamide 1 Docetaxel 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03070886 2026-01-14

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

Phase 2/3 Completed

Stage I Prostate Adenocarcinoma AJCC v7

Data powered by HemOnc (CC BY 4.0) Colophon ⚡